{"id":"W4405222141","doi":"10.1093/brain/awae308","title":"Optimizing rare disorder trials: a phase 1a/1b randomized study of KL1333 in adults with mitochondrial disease","year":2024,"lang":"en","type":"article","venue":"Brain","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Wellcome Trust Centre for Mitochondrial Research; NIHR Newcastle Biomedical Research Centre; Medical Research Council; Centro Singular de Investigación de Galicia; Rosetrees Trust; University College London Hospitals NHS Foundation Trust; NIHR Barts Biomedical Research Centre, Queen Mary University of London; Medical Research Council Canada; Newcastle University; University College London; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Lily Foundation; Muscular Dystrophy UK; Department of Health and Social Care; Wellcome Trust","keywords":"Tolerability; Clinical trial; Mitochondrial disease; Medicine; Orphan drug; Disease; Drug development; Randomized controlled trial; Physical therapy; Internal medicine; Bioinformatics; Drug; Adverse effect; Pharmacology; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006328217,0.001092574,0.001384126,0.0003196083,0.0005939753,0.001129539,0.0004049561,0.001925011,0.00501902],"category_scores_gemma":[0.004584706,0.0004127676,0.001446207,0.0003067875,0.0007941574,0.001129516,0.0005480379,0.00252675,0.0006996061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007142748,"about_ca_system_score_gemma":0.001730291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006187459,"about_ca_topic_score_gemma":0.00160497,"domain_scores_codex":[0.9971373,0.002061455,0.0001720216,0.0002480065,0.0001569519,0.0002243443],"domain_scores_gemma":[0.997961,0.0007329496,0.0004546185,0.0001699325,0.000184962,0.0004965201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9098539,0.01569066,0.002939088,0.001192339,0.001554866,0.0001774787,0.0002022938,0.0006319134,0.008265467,0.0007920268,0.004934266,0.05376587],"study_design_scores_gemma":[0.8753565,0.1154921,0.003262004,0.0001006314,0.0005563706,0.0001000247,0.00003920776,0.0003776501,0.0006683511,0.0005066288,0.003517475,0.00002307065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952305,0.008437126,0.003331658,0.004778107,0.0008106441,0.02295176,0.002482583,0.0002596366,0.004643474],"genre_scores_gemma":[0.9503599,0.003652506,0.01002182,0.004979989,0.0006860277,0.0247953,0.001731536,0.000061701,0.00371133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006328217,"threshold_uncertainty_score":0.03346717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01134214685043658,"score_gpt":0.2968644397288556,"score_spread":0.285522292878419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}